{"id":"phenoxymethylpenicillin","rwe":[],"tags":[],"safety":{"commonSideEffects":[{"effect":"Nausea","drugRate":"reported","severity":"unknown"},{"effect":"Vomiting","drugRate":"reported","severity":"unknown"},{"effect":"Epigastric distress","drugRate":"reported","severity":"unknown"},{"effect":"Diarrhea","drugRate":"reported","severity":"unknown"},{"effect":"Black hairy tongue","drugRate":"reported","severity":"unknown"},{"effect":"Skin eruptions","drugRate":"reported","severity":"unknown"},{"effect":"Urticaria","drugRate":"reported","severity":"unknown"},{"effect":"Laryngeal edema","drugRate":"reported","severity":"unknown"},{"effect":"Anaphylaxis","drugRate":"reported","severity":"unknown"},{"effect":"Fever","drugRate":"reported","severity":"unknown"},{"effect":"Eosinophilia","drugRate":"reported","severity":"unknown"},{"effect":"Hemolytic anemia","drugRate":"infrequent","severity":"mild"},{"effect":"Leukopenia","drugRate":"infrequent","severity":"mild"},{"effect":"Thrombocytopenia","drugRate":"infrequent","severity":"mild"},{"effect":"Neuropathy","drugRate":"infrequent","severity":"mild"},{"effect":"Nephropathy","drugRate":"infrequent","severity":"mild"}],"contraindications":["Infectious mononucleosis","Kidney disease","Pseudomembranous enterocolitis"]},"trials":[],"_chembl":{"chemblId":"CHEMBL615","moleculeType":"Small molecule","molecularWeight":"350.40"},"aliases":["Penicillin V (PcV)","Penicillin V","Primcillin","Marketing Authorisation Number PL; 04520/0005","Weifapenin 650 mg, WEIFA, no. 100"],"patents":[],"pricing":[],"_fixedAt":"2026-03-30T15:54:43.937369","offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"mechanism":{"target":"Bacterial penicillin-binding protein, Penicillin-binding protein 1A","modality":"Small Molecule"},"_scrapedAt":"2026-03-28T00:41:44.808Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Acute otitis media","diseaseId":"acute-otitis-media","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Erysipelas","diseaseId":"erysipelas","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Fusospirochetal pharyngitis","diseaseId":"fusospirochetal-pharyngitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Gingivostomatitis","diseaseId":"gingivostomatitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Infection Prevention from Tooth Extraction","diseaseId":"infection-prevention-from-tooth-extraction","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Infection due to Staphylococcus aureus","diseaseId":"infection-due-to-staphylococcus-aureus","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Infection of skin AND/OR subcutaneous tissue","diseaseId":"infection-of-skin-and/or-subcutaneous-tissue","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Infective otitis media","diseaseId":"infective-otitis-media","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pharyngitis","diseaseId":"pharyngitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pneumococcal Acute Otitis Media","diseaseId":"pneumococcal-acute-otitis-media","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Rheumatic Fever Prevention","diseaseId":"rheumatic-fever-prevention","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Scarlet fever","diseaseId":"scarlet-fever","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Streptococcal tonsillitis","diseaseId":"streptococcal-tonsillitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Streptococcus pyogenes infection","diseaseId":"streptococcus-pyogenes-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Upper Respiratory Pneumococcal Infection","diseaseId":"upper-respiratory-pneumococcal-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Upper Respiratory Streptococcal Infection","diseaseId":"upper-respiratory-streptococcal-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Upper respiratory infection","diseaseId":"upper-respiratory-infection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"_fixedFields":["sideEffects","modality→Small Molecule"],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT05693545","phase":"PHASE2","title":"GOALIE: Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent RHD Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2023-09-01","conditions":"Rheumatic Heart Disease","enrollment":1004},{"nctId":"NCT06295120","phase":"PHASE4","title":"The Optimal Antibiotic Treatment Duration for Community-acquired Pneumonia in Adults Diagnosed in General Practice in Denmark (CAP-D)","status":"RECRUITING","sponsor":"Research Unit for General Practice in Aalborg","startDate":"2023-11-13","conditions":"Community-acquired Pneumonia","enrollment":600},{"nctId":"NCT05082909","phase":"PHASE1, PHASE2","title":"Addition of Probenecid to Penicillin-V Therapy","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2021-12-21","conditions":"Infection, Bacterial","enrollment":21},{"nctId":"NCT04083417","phase":"PHASE4","title":"Sore Throat in Primary Care - a Comparison of Phenoxymethylpenicillin and No Antibiotic Treatment","status":"RECRUITING","sponsor":"Katarina Hedin","startDate":"2019-09-09","conditions":"Sore Throat, Tonsillitis","enrollment":260},{"nctId":"NCT03847610","phase":"PHASE1","title":"Minimally Invasive Sensing of Beta-lactam Antibiotics","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2018-04-12","conditions":"Healthy Volunteers","enrollment":11},{"nctId":"NCT04084106","phase":"PHASE4","title":"Effects of Phenoximethylpenicillin, Amoxicillin and Amoxicillin-clavulanic Acid on the Gut Microbiota","status":"COMPLETED","sponsor":"Uppsala University","startDate":"2019-09-10","conditions":"Infectious Disease","enrollment":104},{"nctId":"NCT02185209","phase":"PHASE4","title":"Surgical Treatment of Peri-implantitis With and Without Systemically Adjunctive Antibiotics","status":"COMPLETED","sponsor":"Margareta Hultin","startDate":"2015-03","conditions":"Periodontal Diseases, Periimplantitis","enrollment":77},{"nctId":"NCT02099240","phase":"EARLY_PHASE1","title":"Patients Response to Early Switch To Oral:Osteomyelitis Study","status":"TERMINATED","sponsor":"Julio Ramirez","startDate":"2014-03-06","conditions":"Osteomyelitis","enrollment":11},{"nctId":"NCT02712307","phase":"PHASE4","title":"Study of 5 and 10 Days Treatment With Penicillin Against Sore Throat Caused by Streptococci","status":"COMPLETED","sponsor":"Ass. Prof. Katarina Hedin","startDate":"2015-09","conditions":"Tonsillitis","enrollment":433},{"nctId":"NCT03326661","phase":"NA","title":"Peritonsillar Abscess: Aspiration Versus Tonsillectomy a Chaud","status":"UNKNOWN","sponsor":"Odense University Hospital","startDate":"2017-11-10","conditions":"Peritonsillar Abscess","enrollment":128},{"nctId":"NCT03293641","phase":"NA","title":"Zinc Supplementation in Children With Sickle Cell Disease in Western Kenya","status":"COMPLETED","sponsor":"Lucas Otieno Tina, MD MSc","startDate":"2016-05-20","conditions":"Sickle Cell Disease, Zinc Deficiency, Infection","enrollment":40},{"nctId":"NCT03208361","phase":"PHASE3","title":"Efficacy of High Doses Penicillin V Versus High Doses Amoxicillin in the Treatment of Non-severe Pneumonia.","status":"TERMINATED","sponsor":"Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina","startDate":"2013-11-05","conditions":"Community-acquired Pneumonia (CAP)","enrollment":43},{"nctId":"NCT00823433","phase":"EARLY_PHASE1","title":"Oral Penicillin and Penicillin Levels in Venous Umbilical Cord Blood","status":"TERMINATED","sponsor":"Corewell Health East","startDate":"2009-01","conditions":"Group B Streptococcus","enrollment":25},{"nctId":"NCT02922686","phase":"PHASE4","title":"Penicillin for the Emergency Department Outpatient Treatment of CELLulitis","status":"UNKNOWN","sponsor":"Royal College of Surgeons, Ireland","startDate":"2016-12","conditions":"Cellulitis, Wound Infection, Abscess","enrollment":414},{"nctId":"NCT01368341","phase":"PHASE4","title":"Comparing 3 Antibiotic Regimes for Erythema Migrans in General Practice","status":"COMPLETED","sponsor":"Morten Lindbaek","startDate":"2011-06","conditions":"Erythema Migrans, Erythema Chronicum Migrans, Borreliosis","enrollment":225},{"nctId":"NCT00615797","phase":"NA","title":"Intravenous Immunoglobulins as Effective Treatment in Sydenham's Chorea","status":"COMPLETED","sponsor":"University of Cape Town","startDate":"2002-05","conditions":"Sydenham Chorea, Post Streptococcal Movement Disorder","enrollment":20},{"nctId":"NCT01499875","phase":"PHASE1","title":"A Pharmacokinetic and Pharmacodynamic Study of Phenoxymethylpenicillin for Children","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2012-01","conditions":"Phenoxymethylpenicillin","enrollment":80},{"nctId":"NCT02188472","phase":"PHASE1","title":"Pentriox - Induction of Oxidative Stress","status":"COMPLETED","sponsor":"Henrik Enghusen Poulsen","startDate":"2010-11","conditions":"Oxidative Stress","enrollment":90},{"nctId":"NCT01734759","phase":"PHASE1","title":"Influence of Medication Taste on Pediatric Prescribers' Prescribing Habits","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2012-11","conditions":"Healthy","enrollment":50},{"nctId":"NCT00784082","phase":"","title":"Inflammatory Response to Hydroxyurea Therapy in Sickle Cell Disease","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2009-05","conditions":"Sickle Cell Disease","enrollment":62},{"nctId":"NCT00552799","phase":"PHASE4","title":"RCT to Investigate if Prophylactic Antibiotics Prevent Further Episodes of Cellulitis (Erysipelas) of the Leg","status":"COMPLETED","sponsor":"University of Nottingham","startDate":"2006-07","conditions":"Cellulitis/Erysipelas of the Leg","enrollment":274},{"nctId":"NCT00315042","phase":"PHASE3","title":"TELI TON - Telithromycin in Tonsillitis","status":"TERMINATED","sponsor":"Sanofi","startDate":"2006-03","conditions":"Tonsillitis, Pharyngitis","enrollment":314},{"nctId":"NCT00315549","phase":"PHASE3","title":"TELI TAD - Telithromycin in Tonsillitis in Adolescents and Adults","status":"TERMINATED","sponsor":"Sanofi","startDate":"2006-02","conditions":"Tonsillitis, Pharyngitis","enrollment":233},{"nctId":"NCT00095368","phase":"PHASE3","title":"APC-111 Once a Day (QD) for 7 Days vs. Penicillin Taken Four Times a Day (QID) for 10 Days in Patients With Strep Throat","status":"COMPLETED","sponsor":"Advancis Pharmaceutical Corporation","startDate":"2004-10","conditions":"Pharyngitis, Tonsillitis","enrollment":500},{"nctId":"NCT00242281","phase":"PHASE3","title":"APC-111 MP Tablet Once a Day vs.Penicillin VK Four Times a Day Both for 10 Days in Patients With Strep Throat","status":"COMPLETED","sponsor":"Advancis Pharmaceutical Corporation","startDate":"2005-11","conditions":"Sore Throat, Pharyngitis, Tonsillitis","enrollment":600},{"nctId":"NCT00100126","phase":"PHASE3","title":"APC-231 Once a Day (QD) for 7 Days vs. Penicillin Taken Four Times a Day (QID) in Pediatric Patients With Strep Throat","status":"COMPLETED","sponsor":"Advancis Pharmaceutical Corporation","startDate":"2004-12","conditions":"Pharyngitis","enrollment":500}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":540,"therapeuticAreas":["Immunology"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Phenoxymethylpenicillin","genericName":"Phenoxymethylpenicillin","companyName":"Katarina Hedin","companyId":"katarina-hedin","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Phenoxymethylpenicillin, also known as penicillin V, is a small molecule inhibitor of bacterial penicillin-binding protein. It is used to treat bacterial infections such as strep throat, otitis media, and cellulitis, as well as to prevent rheumatic fever and infections following removal of the spleen.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}